caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972568723

Siri AkalMD

Family PracticeSt Thomas, VII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,198
Unique beneficiaries
—
Total services
1,568
Distinct HCPCS
14
Medicare payment
$87K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10 Family Practice providers in VI — top quintile (cohort median 865).
REFERRAL NETWORK

Where Siri Akal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
VI GOVERNMENT HOSPITAL AND HEALTH FACILITIES CORP3499
George Rosenberg
Diagnostic Radiology · St. Thomas, VI
2852
GULLER, JEFFREY2660
Community Medical Laboratory, Inc.
Clinical Laboratory · St Thomas, VI
2453
Clayton Wheatley
Emergency Medicine · St. Thomas, VI
2354
JOHNSON, JOY2237
Roy Flood
Interventional Cardiology · Savannah, GA
2064
NPI 12654220911122
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
3,232
Beneficiaries
—
Total drug cost
$255K
Distinct drugs
76
Brand share
27.5%
Top prescribed drugs
Amlodipine Besylate255 claims
Atorvastatin Calcium228 claims
Losartan Potassium163 claims
Rosuvastatin Calcium143 claims
Metformin Hcl134 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
83.0
Quality
59.2
Cost
97.8
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.34%
Group